Obstetric cholestasis, outcome with active management: a series of 70 cases.

BJOG

Guy's, Kings' and St Thomas' Hospital School of Medicine, Maternal and Fetal Research Unit, St Thomas' Hospital, London, UK.

Published: March 2002

Objective: To determine the nature and outcome of obstetric cholestasis in a United Kingdom population.

Design: Prospective analysis of clinical outcome in women diagnosed with obstetric cholestasis that is actively managed.

Setting: Antenatal population of three London hospitals between August 1999 and April 2001.

Population: Seventy women with obstetric cholestasis defined as abnormal liver function (one or more abnormality in gamma-glutamyl transpeptidase, alanine amino-transferase, aspartate amino-transferase and total bile acids) in a pregnant woman with pruritus, in the absence of other pathology.

Methods: All women were interviewed weekly regarding their symptoms. All were actively managed according to a standardised protocol, which included early delivery before 38 weeks. Obstetric outcome was recorded.

Results: Seventy women of mean age 30 (6) years delivered 73 infants. The median gestation at onset of pruritus was 30 (range 4-39) weeks and at diagnosis of obstetric cholestasis was 33.7 (range 21-40.7) weeks. Asian women were more likely to be diagnosed with obstetric cholestasis. Pruritus was usually severe and generalised, and commonly worst on the palms and/or soles of the feet. There were no stillbirths or perinatal deaths. Twenty-five women required caesarean section (36%); only four (16%) were for fetal distress. Twelve women (17%) delivered before 37 weeks, of which eight (67%) were iatrogenic. Ten (14%) infants required admission to the special care baby unit of which four (40%) were ventilated.

Conclusions: Policies of active management result in increased intervention and associated complications. This must be balanced against possible reductions in perinatal mortality.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1471-0528.2002.01368.xDOI Listing

Publication Analysis

Top Keywords

obstetric cholestasis
24
active management
8
women diagnosed
8
diagnosed obstetric
8
seventy women
8
obstetric
7
women
7
cholestasis
5
outcome
4
cholestasis outcome
4

Similar Publications

Background/aim: Two retrospective studies of prospective cohorts showed doubled odds of birth asphyxia among women with low plasma vitamin D levels, and another study reported a four-fold increased risk of stillbirth. It was not known whether this was related to low sun exposure or to insufficient vitamin D per se. We aimed to assess if it was due to vitamin D status.

View Article and Find Full Text PDF

Objectives: To analyze pregnancy outcomes and factors influencing early-onset intrahepatic cholestasis of pregnancy (ICP), offering insights to improve the management, diagnosis, and treatment of ICP during pregnancy.

Methods: We categorized 127 pregnant women with ICP into two groups based on a gestational age cutoff of 28 weeks. The analysis centered on biochemical markers, pregnancy complications, and outcomes to identify factors influencing early-onset ICP.

View Article and Find Full Text PDF

Relationship between HBV RNA level and pregnancy outcomes among hepatitis B carriers.

J Med Biochem

September 2024

Guizhou Medical University, Affiliated Hospital, Department of Infectious Diseases, Guiyang, China.

Background: This study aims to investigate the relationship between hepatitis B virus (HBV) RNA level and pregnancy outcomes among hepatitis B carriers.

Methods: This study collected pregnant women who attended the Affiliated Hospital of Guizhou Medical University (Guizhou, China) from June 2020 to June 2023. The levels of HBV DNA, HBV RNA, and HBeAg status in HBV carriers were detected.

View Article and Find Full Text PDF

Women with intrahepatic cholestasis of pregnancy (ICP) have hypercholanemia alongside an increased risk of dyslipidemia. We investigated how cholic acid (CA) supplementation in murine pregnancy impacts adipose tissue function. Mice were fed normal or 0.

View Article and Find Full Text PDF

Detection of serum lactate dehydrogenase A and its metabolites on placental function in patients with intrahepatic cholestasis of pregnancy.

Int Immunopharmacol

January 2025

Wuxi Maternity and Child Health Care Hospital, Affiliated Women's Hospital of Jiangnan University, Jiangnan University, Wuxi 214002, China. Electronic address:

Article Synopsis
  • Intrahepatic cholestasis of pregnancy (ICP) is a liver disease diagnosed mainly by serum total bile acid levels, but this method lacks sensitivity and specificity.
  • Recent research identifies lactate dehydrogenase A (LDHA) as a potential new biomarker, which is highly expressed in ICP patients and detected using DIA proteomic technology.
  • A study developed a novel immunochromatographic test strip to quantitatively measure LDHA levels and explored its role in the inflammatory mechanisms of ICP, suggesting LDHA may be a promising target for improved diagnosis and treatment strategies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!